<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01831115</url>
  </required_header>
  <id_info>
    <org_study_id>BASEL V</org_study_id>
    <nct_id>NCT01831115</nct_id>
  </id_info>
  <brief_title>Basics in Acute Shortness of Breath EvaLuation (BASEL V) Study</brief_title>
  <acronym>BASEL V</acronym>
  <official_title>Basics in Acute Shortness of Breath EvaLuation (BASEL V) Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swiss National Science Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To improve the diagnostic and prognostic utility of various biomarkers, detailed patient's&#xD;
      history, physical examinations and technical devices in patients presenting with acute&#xD;
      dyspnea.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Acute heart failure is a common disease associated with high morbidity and&#xD;
      mortality. Unfortunately, pathophysiology and optimal initial treatment are both ill defined.&#xD;
&#xD;
      Working Hypothesis:&#xD;
&#xD;
        -  Improved understanding of the pathophysiology underlying heart failure might allow more&#xD;
           cause-specific treatment to this syndrome.&#xD;
&#xD;
        -  More rapid diagnosis of acute heart failure may allow to more rapidly initiate the&#xD;
           appropriate treatment.&#xD;
&#xD;
        -  Cardiac dysfunction especially in comorbid dyspneic patients is not adequately&#xD;
           characterized and the spectrum of acute heart failure is more diverse than originally&#xD;
           thought.&#xD;
&#xD;
      Methods: This is a large multicenter center, observational study enrolling unselected,&#xD;
      consecutive patients with acute dyspnea presenting to the Emergency Department. Patient&#xD;
      history, physical examination and laboratory parameters will be systematically obtained.&#xD;
      Echocardiographic examinations will be routinely performed. Follow-up will be done at&#xD;
      specified intervals (3, 6 and 12 months) after the initial presentation and risk predictors&#xD;
      will be analyzed in multivariable regression models.&#xD;
&#xD;
      Expected Value of the Proposed Project: The data obtained during this project will help to&#xD;
      further improve diagnostics and prognostics in patients with acute dyspnea and to better&#xD;
      understand underlying pathology of cardiac dysfunction in this cohort.&#xD;
&#xD;
      Significance: The study aims are up-to-date and deal with an important health care problem in&#xD;
      society. Conclusions drawn will significantly change care of patients with acute heart&#xD;
      failure probably leading to a significant reduction of rehospitalization, morbidity and&#xD;
      mortality.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic accuracy for the diagnosis of heart failure</measure>
    <time_frame>baseline</time_frame>
    <description>Diagnostic of various biomarkers (such as natriuretic peptides, cardiac troponins, microRNA...), physical examination, detailed patient's history and novel technical devices.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prognostic utility in patients with dyspnea</measure>
    <time_frame>360 days</time_frame>
    <description>Prognostic value of various biomarkers, echocardiography data and novel technical measurements regarding rehospitalisation, cardiovascular mortality and all-cause and mortality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prognostic utility in patients with dyspnea</measure>
    <time_frame>720 days</time_frame>
    <description>Prognostic value of various biomarkers, echocardiography data and novel technical measurements regarding rehospitalisation, cardiovascular mortality and all-cause and mortality</description>
  </primary_outcome>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Dyspnea</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      EDTA, Plasma and Urine&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting with acute dyspnea to the emergency department.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  chief complaint of dyspnea (not penetrating injury or trauma related)&#xD;
&#xD;
          -  subjects must be at least 18 years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patient is unable or unwilling to give informed consent&#xD;
&#xD;
          -  patient on hemodialysis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 4, 2013</study_first_submitted>
  <study_first_submitted_qc>April 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2013</study_first_posted>
  <last_update_submitted>April 29, 2021</last_update_submitted>
  <last_update_submitted_qc>April 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Basel, Switzerland</investigator_affiliation>
    <investigator_full_name>Christian MÃ¼ller, MD</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>heart failure</keyword>
  <keyword>BNP</keyword>
  <keyword>acute dyspnoea</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyspnea</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

